Biolytx

Oklahoma City, US · 1 known investors

Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.

BiotechMedical Devices